Teva Pharmaceutical Balance Sheet - Annual (NYSE:TEVA)

Add to My Stocks
$17.68 $0.23 (1.28%) TEVA stock closing price Mar 20, 2018 (Closing)

The financial analysis of a company like Teva Pharmaceutical involves checking the three financial statements of the company in detail, of which the balance sheet is one. All three financial statements should be used to measure the financial performance of the company, and should form a part of the Teva Pharmaceutical stock analysis. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. The balance sheet shows total liabilities of $57.9B and shareholders equity of $34.99B. Teva Pharmaceutical revenue and Teva Pharmaceutical operating cash flow are important in understanding the financial capacity of the company.

View latest 10 year balance sheet data to check Teva Pharmaceutical financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011201020092008
Marketable Securities------36M253M53M
Raw Materials1.58B1.38B1.47B1.77B1.88B1.73B---
Work In Progress538M535M638M715M751M781M---
Finished Goods2.83B2.05B2.27B2.57B2.87B2.5B---
Notes Receivable---------
Other Current Assets3.5B2.14B2.39B2.29B2.4B2.13B1.42B1.54B1.47B
Total Current Assets
Property Plant & Equipment11.93B10.07B9.88B9.74B9.14B8.38B---
Accumulated Depreciation3.85B3.53B3.35B3.11B2.82B2.43B---
Net Property Plant & Equipment
Investment & Advances-----991M632M534M425M
Other Non-Current Assets---------
Deferred Charges725M----142M138M642M-
Deposits & Other Assets1.24B2.62B1.57B1.7B1.34B---476M
Total Assets
Notes Payable------2.77B1.3B2.91B
Accounts Payable2.16B3.59B3.17B3.32B3.38B3.74B2.53B2.68B2.24B
Current Portion Long-Term Debt3.28B1.59B1.76B1.8B3.01B4.28B---
Current Portion Capital Leases---------
Accrued Expenses4.26B--------
Income Taxes Payable---------
Other Current Liabilities8.82B7.83B7.36B6.84B6.51B5.82B4.4B3.62B3.33B
Total Current Liabilities
Deferred Taxes/Income5.22B1.75B1.1B1.25B1.85B2.61B1.35B1.74B1.72B
Convertible Debt------13M817M1.88B
Long-Term Debt32.52B8.38B8.57B10.39B11.71B10.24B4.1B3.49B3.65B
Non-Current Capital Leases---------
Other Long-Term Liabilities1.64B1.2B1.11B1.27B1.29B1.11B998M897M803M
Total Liabilities
Minority Interest--------60M
Preferred Stock3.62B3.29B-------
Common Stock Net54M52M50M50M50M50M49M49M48M
Capital Surplus23.41B17.76B14.12B13.63B13.47B13.37B13.25B12.88B11.5B
Retained Earnings13.61B14.85B14.44B12.54B12.35B11.28B9.33B6.66B5.29B
Treasury Stock4.19B4.23B3.95B3.56B3.09B1.92B1.02B924M924M
Other Liabilities-1.5B-1.8B-1.3B-20M82M-441M405M592M390M
Shareholders Equity34.99B29.93B23.36B22.64B22.87B22.34B22B19.26B16.3B
Total Liabilities & Shareholders Equity92.89B54.26B46.42B47.51B50.61B50.14B38.15B33.81B32.9B
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The latest Teva Pharmaceutical stock price, and Teva Pharmaceutical historical stock prices show the stock price movement over time, and the Teva Pharmaceutical PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: An asset is a resource that a corporation like Teva Pharmaceutical owns and has monetary significance. TEVA assets grew from $54.26B in 2015 to $92.89B in 2016. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Teva Pharmaceutical's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for TEVA stock stand at $57.9B.

Teva Pharmaceutical Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio